株探米国株
日本語 英語
エドガーで原本を確認する
false 0001308547 0001308547 2025-11-18 2025-11-18
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

November 18, 2025

 

 

DOLBY LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-32431   90-0199783
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
 

(IRS Employer

Identification No.)

1275 Market Street

San Francisco, CA 94103-1410

(Address of principal executive offices) (Zip Code)

(415) 558-0200

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Class A common stock, $0.001 par value   DLB   The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 2.02

Results of Operations and Financial Condition.

The following information is intended to be furnished under Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

On November 18, 2025, Dolby Laboratories, Inc. (the “Company”) issued a press release announcing its financial results for its fiscal quarter and fiscal year ended September 26, 2025. The full text of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference.

 

Item 8.01

Other Events

Declaration of Dividend

On November 18, 2025, the Company announced a cash dividend of $0.36 per share of Class A and Class B Common Stock, payable on December 10, 2025 to stockholders of record as of the close of business on December 2, 2025.

Disclosure Channels to Disseminate Information

The Company disseminates information to the public about the Company, its products, services and other matters through various channels, including the Company’s website (www.dolby.com), investor relations website (http://investor.dolby.com), SEC filings, press releases, public conference calls and webcasts, in order to achieve broad, non-exclusionary distribution of information to the public. The Company encourages investors and others to review the information it makes public through these channels, as such information could be deemed to be material information.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit
No.

  

Description

99.1    Press Release of Dolby Laboratories, Inc. dated November 18, 2025
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  DOLBY LABORATORIES, INC.
By:  

/s/ Robert Park

 

Robert Park

Senior Vice President and Chief Financial Officer (Principal Financial Officer)

Date: November 18, 2025

EX-99.1 2 d949940dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2025 Financial

Results

SAN FRANCISCO, November 18, 2025 — Dolby Laboratories, Inc. (NYSE:DLB) today announced the company’s financial results for the fourth quarter and fiscal year 2025.

“We finished FY25 strong, growing Dolby Atmos, Dolby Vision and imaging patents, and expanding our addressable market with momentum in Dolby OptiView and the introduction of a new imaging patent pool for content streamers,” said Kevin Yeaman, President and CEO, Dolby Laboratories. “As we head into FY26, I’m confident in our strategy to grow our business by delivering value across current and future ecosystems of creatives, content distributors and device makers.”

Fourth Quarter Fiscal 2025 Financial Highlights

 

   

Total revenue was $307 million, compared to $305 million for the fourth quarter of fiscal 2024.

 

   

GAAP net income was $49 million or $0.51 per diluted share, compared to GAAP net income of $59 million or $0.61 per diluted share for the fourth quarter of fiscal 2024. On a non-GAAP basis, fourth quarter net income was $96 million or $0.99 per diluted share, compared to $78 million or $0.81 per diluted share for the fourth quarter of fiscal 2024. Fourth quarter net income included a benefit from discrete tax items of $0.19 per diluted share on a GAAP basis and $0.28 per diluted share on a non-GAAP basis.

 

   

Dolby repurchased approximately 479,000 shares of its common stock for approximately $35 million, and ended the quarter with approximately $277 million of stock repurchase authorization available going forward.

Full Year Fiscal 2025 Financial Highlights

 

   

Total revenue was $1.35 billion, compared to $1.27 billion for the full year of fiscal 2024.

 

   

GAAP net income was $255 million, or $2.62 per diluted share, compared to GAAP net income of $262 million, or $2.69 per diluted share, for the full year of fiscal 2024. On a non-GAAP basis, full year net income was $414 million or $4.24 per diluted share, compared to $369 million or $3.79 per diluted share for the full year of fiscal 2024.

 

   

Cash flows from operations were $472 million, compared to $327 million for the full year of fiscal 2024.

A complete listing of Dolby’s non-GAAP measures are described and reconciled to the corresponding GAAP measures at the end of this release.

Recent Business Highlights

 

   

Peacock started streaming its NFL Sunday Night Football games and NBA games in Dolby Atmos.

 

   

In September we announced Dolby Vision 2, which expands the benefits of Dolby Vision beyond HDR, unlocking the full capabilities of modern displays and introducing new tools for artists.

 

   

This quarter, TCL, Samsung, Hisense, Xiaomi, and Amazon launched TVs that feature Dolby Atmos and/or Dolby Vision.

 

   

Instagram for iOS is now the first Meta app to support Dolby Vision.

 

   

Douyin, known in many parts of the world as TikTok, made Dolby Vision available to its users in China, giving them the ability to capture, share, and edit content in Dolby Vision.

 

   

This past quarter, we signed agreements with automakers Maruti Suzuki in India, Deepal in China, and VinFast in Vietnam.

 

   

The first in-car game featuring Dolby Atmos, Loner, officially launched on Li Auto vehicles.


Upcoming Investor Event

Dolby is hosting an event at CES for the financial community where we will demonstrate a wide array of our technologies. The event will be held at 8:00 a.m. PT on Wednesday, January 7, 2026. Please send an email to IR@dolby.com for more information.

Dividend

Today, Dolby announced a cash dividend of $0.36 per share of Class A and Class B common stock, payable on December 10, 2025, to stockholders of record as of the close of business on December 2, 2025.

Financial Outlook

Dolby’s financial outlook relies, in part, on estimates of royalty-based revenue that take into consideration various factors that are subject to uncertainty, including consumer demand for electronic products. In addition, actual results could differ materially from the estimates Dolby is providing below due in part to uncertainty resulting from the macroeconomic effect of certain conditions, including developments concerning trade restrictions and changes in trade or diplomatic relationships, supply chain constraints, international conflicts, geopolitical instability, and fluctuations in inflation and interest rates. The uncertainty resulting from these factors has greatly reduced visibility into Dolby’s future outlook. To the extent possible, the estimates Dolby is providing for future periods reflect certain assumptions about the potential impact of certain of these items, based upon a consideration of currently available external and internal data and information. These assumptions are subject to risks and uncertainties. For more information, see “Forward-Looking Statements” in this press release for a description of certain risks that Dolby faces, and the section captioned “Risk Factors” in its Annual Report on Form 10-K for fiscal 2025, to be filed on or around the date hereof.

Dolby is providing the following estimates for its first quarter of fiscal 2026:

 

   

Total revenue is estimated to range from $315 million to $345 million.

 

   

Licensing revenue is estimated to range from $290 million to $320 million.

 

   

Gross margins are anticipated to be approximately 88% on a GAAP basis and approximately 90% on a non-GAAP basis.

 

   

Operating expenses are anticipated to range from $235 million to $245 million on a GAAP basis and from $195 million to $205 million on a non-GAAP basis.

 

   

Effective tax rate is anticipated to be around 23% on a GAAP basis and around 21% on a non-GAAP basis.

 

   

Diluted earnings per share is anticipated to range from $0.39 to $0.54 on a GAAP basis and from $0.79 to $0.94 on a non-GAAP basis.

Dolby is providing the following estimates for the full year of fiscal 2026:

 

   

Total revenue is expected to range from $1.390 billion to $1.440 billion.

 

   

Licensing revenue is estimated to range from $1.285 billion to $1.335 billion.

 

   

Gross margins are anticipated to be approximately 88% on a GAAP basis and approximately 90% on a non-GAAP basis.

 

   

Operating expenses are anticipated to range from $930 million to $950 million on a GAAP basis and from $780 million to $800 million on a non-GAAP basis.

 

   

Dolby expects operating margins to be roughly 21% on a GAAP basis and to be roughly 34% on a non-GAAP basis.

 

   

Effective tax rate is anticipated to be around 23% on a GAAP basis and around 21% on a non-GAAP basis.

 

   

Diluted earnings per share is anticipated to range from $2.61 to $2.76 on a GAAP basis and from $4.19 to $4.34 on a non-GAAP basis.


Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss fourth quarter and full year fiscal 2025 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Tuesday, November 18, 2025. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-888-210-2212 (+1-646-960-0390 for international callers) and entering confirmation code 5587811.

A replay of the call will be available from 5:00 p.m. PT (8:00 p.m. ET) on Tuesday, November 18, 2025, until 8:59 p.m. PT (11:59 p.m. ET) on Tuesday, November 25, 2025 by dialing 1-800-770-2030 (+1-647-362-9199 for international callers) and entering the confirmation code 5587811. An archived version of the teleconference will also be available on the Dolby website, http://investor.dolby.com.

Non-GAAP Financial Information

To supplement Dolby’s financial statements presented on a GAAP basis, Dolby management uses, and Dolby provides to investors, certain non-GAAP financial measures as an additional tool to evaluate Dolby’s operating results in a manner that focuses on what Dolby’s management believes to be its ongoing business operations and performance. We believe these non-GAAP financial measures are also helpful to investors in enabling comparability of operating performance between periods and among peer companies. Additionally, Dolby’s management regularly uses our supplemental non-GAAP financial measures to make operating decisions, for planning and forecasting purposes and determining bonus payouts. Specifically, Dolby excludes the following as adjustments from one or more of its non-GAAP financial measures:

Stock-based compensation expense: Stock-based compensation, unlike cash-based compensation, utilizes subjective assumptions in the methodologies used to value the various stock-based award types that Dolby grants. These assumptions may differ from those used by other companies. To facilitate more meaningful comparisons between its underlying operating results and those of other companies, Dolby excludes stock-based compensation expense.

Amortization of acquisition-related intangibles: Dolby amortizes intangible assets acquired in connection with business combinations. These intangible assets consist of patents and technology, customer relationships, and other intangibles. Dolby records amortization charges relating to these intangible assets in its GAAP financial statements, and Dolby views these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of its acquisitions. As these amortization charges do not directly correlate to its operations during any particular period, Dolby excludes these charges to facilitate an evaluation of its current operating performance and comparisons to its past operating results. In addition, while amortization expense of acquisition-related intangible assets is excluded from Non-GAAP Net Income, the revenue generated from those assets is not excluded.

Restructuring charges or credits: Restructuring charges are costs associated with restructuring plans and primarily relate to costs associated with exit or disposal activities, employee severance benefits, and asset impairments. Dolby excludes restructuring costs, including any adjustments to charges recorded in prior periods (which may be credits), as Dolby believes that these costs are not representative of its normal operating activities and therefore, excluding these amounts enables a more effective comparison of its past operating performance and to that of other companies.

Income tax adjustments: The income tax effects of the aforementioned non-GAAP adjustments do not directly correlate to its operating performance so Dolby believes that excluding such income tax effects provides a more meaningful view of its underlying operating results to management and investors.

Impact from Tax Reform: The enactment of the U.S. Tax Cuts and Jobs Act (Tax Reform), and any related amendments or revisions, requires certain discrete and infrequent charges that are not representative of current operating results and therefore, excluding these amounts enables a more effective comparison to our past operating performance.


Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby’s management believes it is useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby’s business, including as a means to evaluate period-to-period comparisons. Dolby’s management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, superior to, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above and below. Investors are also encouraged to review Dolby’s GAAP financial statements as reported in its US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby investor relations website, http://investor.dolby.com.

Forward-Looking Statements

Certain statements in this press release and in our earnings calls, including, but not limited to, expected financial results for the first quarter of fiscal 2026 and full year fiscal 2026, Dolby’s ability to expand existing business, navigate challenging periods, pursue its long-term growth opportunities, and advance its other long-term objectives are “forward-looking statements” that inherently involve substantial risks and uncertainties. These forward-looking statements are based on management’s current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those provided. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: the potential impacts of economic conditions on Dolby’s business operations, financial results, and financial position (including the impact to Dolby partners and disruption of the supply chain and delays in shipments of consumer products; the level at which Dolby technologies are incorporated into products and the consumer demand for such products; delays in the development and release of new products or services that contain Dolby technologies; delays in royalty reporting or delinquent payment by partners or licensees; lengthening sales cycles; the impact to the overall cinema market including adverse impact to Dolby’s revenue recognized on box-office sales and demand for cinema products and services; and macroeconomic conditions that affect discretionary spending and access to products that contain Dolby technologies); risks associated with geopolitical issues and international conflicts; risks associated with trends in the markets in which Dolby operates, including the broadcast, mobile, consumer electronics, PC, and other markets; the loss of, or reduction in sales by, a key customer, partner, or licensee; pricing pressures; risks relating to changing trends in the way that content is distributed and consumed; risks relating to conducting business internationally, including trade restrictions and changes in diplomatic or trade relationships; risks relating to maintaining patent coverage; the timing of Dolby’s receipt of royalty reports and payments from its licensees, including recoveries; changes in tax regulations; timing of revenue recognition under licensing agreements and other contractual arrangements; Dolby’s ability to develop, maintain, and strengthen relationships with industry participants; Dolby’s ability to develop and deliver innovative products and technologies in response to new and growing markets; competitive risks; risks associated with conducting business in countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the health of the motion picture and cinema industries generally; Dolby’s ability to increase its revenue streams and to expand its business generally, and to continue to expand its business beyond its current technology offerings; risks associated with acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolby’s SEC filings and reports, including the risks identified under the section captioned “Risk Factors” in its Annual Report on Form 10-K filed on or around the date hereof. Dolby may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements. Forward-looking statements are based upon information available to us as of the date of such statements, and while Dolby believes such information forms a reasonable basis for such statements, such information may be limited or incomplete. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Except as required by law, Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

About Dolby

Dolby Laboratories (NYSE: DLB) is a world leader in immersive entertainment. From movies and TV, to music, sports, gaming, and beyond, Dolby transforms the science of sight and sound into spectacular experiences for billions of people worldwide across all their favorite devices. We partner with artists, storytellers, and the brands you love to transform entertainment and digital experiences through groundbreaking innovations like Dolby Atmos, Dolby Vision, Dolby Cinema, and Dolby OptiView.

Dolby, Dolby Atmos, Dolby Vision, Dolby Cinema, Dolby OptiView, and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories in the United States and/or other countries. Other trademarks remain the property of their respective owners.


DOLBY LABORATORIES, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts; unaudited)

 

     Fiscal Quarter Ended     Fiscal Year Ended  
     September 26,
2025
    September 27,
2024
    September 26,
2025
    September 27,
2024
 

Revenue:

        

Licensing

   $ 281,627     $ 282,705     $ 1,248,017     $ 1,181,794  

Products and services

     25,397       22,101       101,113       91,927  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total revenue

     307,024       304,806       1,349,130       1,273,721  
  

 

 

   

 

 

   

 

 

   

 

 

 

Cost of revenue:

        

Cost of licensing

     21,111       18,764       83,619       67,204  

Cost of products and services

     18,408       15,232       76,513       73,292  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total cost of revenue

     39,519       33,996       160,132       140,496  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     267,505       270,810       1,188,998       1,133,225  
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating expenses:

        

Research and development

     67,465       68,636       261,792       263,663  

Sales and marketing

     90,520       87,901       360,711       334,460  

General and administrative

     73,715       69,209       286,529       270,392  

Restructuring charges/(credits)

     6,128       (1,290     15,007       6,384  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     237,828       224,456       924,039       874,899  
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     29,677       46,354       264,959       258,326  
  

 

 

   

 

 

   

 

 

   

 

 

 

Other income/(expense):

        

Interest income/(expense), net

     5,060       6,854       15,376       34,077  

Other income, net

     6,931       6,526       23,150       20,076  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total other income

     11,991       13,380       38,526       54,153  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

     41,668       59,734       303,485       312,479  

Provision for/(benefit from) income taxes

     7,986       (868     (46,993     (48,163
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income including noncontrolling interest

     49,654       58,866       256,492       264,316  

Less: net income attributable to noncontrolling interest

     (322     (296     (1,474     (2,491
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to Dolby Laboratories, Inc.

   $ 49,332     $ 58,570     $ 255,018     $ 261,825  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income per share:

        

Basic

   $ 0.52     $ 0.61     $ 2.66     $ 2.74  

Diluted

   $ 0.51     $ 0.61     $ 2.62     $ 2.69  

Weighted-average shares outstanding:

        

Basic

     95,632       95,395       95,868       95,544  

Diluted

     96,846       96,593       97,479       97,325  


DOLBY LABORATORIES, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands; unaudited)

 

     September 26,
2025
    September 27,
2024
 

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 701,893     $ 482,047  

Restricted cash

     91,468       95,705  

Short-term investments

     703       —   

Accounts receivable, net

     331,096       315,465  

Contract assets, net

     180,804       197,478  

Inventories, net

     30,424       33,728  

Prepaid expenses and other current assets

     51,873       69,994  
  

 

 

   

 

 

 

Total current assets

     1,388,261       1,194,417  

Long-term investments

     80,205       89,267  

Property, plant, and equipment, net

     470,608       479,109  

Operating lease right-of-use assets

     33,204       39,046  

Goodwill and intangible assets, net

     926,957       967,722  

Deferred taxes

     214,361       219,758  

Other non-current assets

     114,164       120,609  
  

 

 

   

 

 

 

Total assets

   $ 3,227,760     $ 3,109,928  
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

    

Current liabilities:

    

Accounts payable

   $ 17,840     $ 17,380  

Accrued liabilities

     369,256       347,529  

Income taxes payable

     8,928       9,045  

Contract liabilities

     31,382       31,644  

Operating lease liabilities

     10,384       12,238  
  

 

 

   

 

 

 

Total current liabilities

     437,790       417,836  

Non-current contract liabilities

     29,687       34,593  

Non-current operating lease liabilities

     28,494       34,754  

Other non-current liabilities

     99,843       135,852  
  

 

 

   

 

 

 

Total liabilities

     595,814       623,035  

Stockholders’ equity:

    

Class A common stock

     54       53  

Class B common stock

     40       41  

Retained earnings

     2,634,980       2,496,255  

Accumulated other comprehensive loss

     (12,517     (19,187
  

 

 

   

 

 

 

Total stockholders’ equity – Dolby Laboratories, Inc.

     2,622,557       2,477,162  

Noncontrolling interest

     9,389       9,731  
  

 

 

   

 

 

 

Total stockholders’ equity

     2,631,946       2,486,893  
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 3,227,760     $ 3,109,928  
  

 

 

   

 

 

 


DOLBY LABORATORIES, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands; unaudited)

 

     Fiscal Year Ended  
     September 26,
2025
    September 27,
2024
 

Operating activities:

    

Net income including noncontrolling interest

   $ 256,492     $ 264,316  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization

     87,827       75,559  

Stock-based compensation

     128,514       119,825  

Amortization of operating lease right-of-use assets

     10,770       11,768  

Amortization of premium on investments

     —        (2,919

Provision for/(benefit from) credit losses

     2,434       (2,256

Deferred income taxes

     4,988       (21,612

Share of net income of equity method investees, net of cash distributions

     (707     (2,023

Other non-cash items affecting net income

     (1,108     3,305  

Changes in operating assets and liabilities:

    

Accounts receivable, net

     (18,463     (28,967

Contract assets, net

     16,680       (8,707

Inventories

     8,019       (2,654

Operating lease right-of-use assets

     (4,505     (8,420

Prepaid expenses and other assets

     15,223       (2,013

Accounts payable and accrued liabilities

     22,851       (34,554

Income taxes, net

     (42,829     (4,501

Contract liabilities

     (5,079     (9,738

Operating lease liabilities

     (8,503     (5,263

Other non-current liabilities

     (406     (13,894
  

 

 

   

 

 

 

Net cash provided by operating activities

     472,198       327,252  
  

 

 

   

 

 

 

Investing activities:

    

Purchases of marketable securities

     —        (160,198

Proceeds from sales of marketable securities

     15,911       234,061  

Proceeds from maturities of marketable securities

     —        157,729  

Proceeds from sale of assets held for sale

     16,881       —   

Purchases of property, plant, and equipment

     (36,348     (30,007

Business combinations, net of cash and restricted cash acquired, and other related payments

     (1,362     (487,877

Purchases of intangible assets

     (5,593     —   

Purchases of other investments

     (75     —   
  

 

 

   

 

 

 

Net cash used in investing activities

     (10,586     (286,292
  

 

 

   

 

 

 

Financing activities:

    

Proceeds from issuance of common stock

     43,697       40,203  

Repurchase of common stock

     (124,992     (160,001

Payment of excise tax on repurchase of common stock

     (261     —   

Payment of cash dividend

     (126,599     (114,579

Distributions to noncontrolling interest

     (1,847     (5,164

Purchase of noncontrolling interest in business combinations

     —        (9,920

Shares repurchased for tax withholdings on vesting of restricted stock

     (37,236     (39,075

Equity issued in connection with business combination

     —        722  
  

 

 

   

 

 

 

Net cash used in financing activities

     (247,238     (287,814
  

 

 

   

 

 

 

Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash

     1,235       6,640  
  

 

 

   

 

 

 

Net increase/(decrease) in cash, cash equivalents, and restricted cash

     215,609       (240,214

Cash, cash equivalents, and restricted cash at beginning of period

     577,752       817,966  
  

 

 

   

 

 

 

Cash, cash equivalents, and restricted cash at end of period

   $ 793,361     $ 577,752  
  

 

 

   

 

 

 


Licensing Revenue by Market

(unaudited)

The following table presents the composition of our licensing revenue and percentage of total licensing revenue for all periods presented (in thousands, except percentage amounts):

 

     Fiscal Quarter Ended     Fiscal Year Ended  
Market    September 26,
2025
    September 27,
2024
    September 26, 2025     September 27, 2024  

Broadcast

   $ 107,174        38   $ 95,779        34   $ 428,471        34   $ 409,105        35

Mobile

     50,626        18     48,701        17     268,568        22     235,774        20

CE

     35,036        12     42,024        15     150,704        12     165,817        14

PC

     28,647        10     34,077        12     151,894        12     141,300        12

Other

     60,144        22     62,124        22     248,380        20     229,798        19
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total licensing revenue

   $ 281,627        100   $ 282,705        100   $ 1,248,017        100   $ 1,181,794        100
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

GAAP to Non-GAAP Reconciliations

(unaudited)

The following tables present Dolby’s GAAP financial measures reconciled to the non-GAAP financial measures included in this release for the fourth quarter and fiscal years ended September 26, 2025, and September 27, 2024:

 

Net income:    Fiscal Quarter Ended     Fiscal Year Ended  
(in thousands)    September 26,
2025
    September 27,
2024
    September 26,
2025
    September 27,
2024
 

GAAP net income attributable to Dolby Laboratories, Inc.

   $ 49,332     $ 58,570     $ 255,018     $ 261,825  

Stock-based compensation (1)

     31,052       29,679       128,514       119,825  

Amortization of acquisition-related intangibles (2)

     10,115       6,296       40,856       15,552  

Restructuring charges/(credits)

     6,128       (1,290     15,007       6,384  

Impact of Tax Reform

     8,836       (10,042     8,836       (10,042

Income tax adjustments

     (9,211     (4,777     (34,720     (24,528
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP net income attributable to Dolby Laboratories, Inc.

   $ 96,252     $ 78,436     $ 413,511     $ 369,016  
  

 

 

   

 

 

   

 

 

   

 

 

 

(1) Stock-based compensation included in above line items:

        

Cost of products and services

   $ 426     $ 362     $ 1,747     $ 1,501  

Research and development

     9,284       9,703       38,500       38,214  

Sales and marketing

     10,606       9,994       44,480       40,128  

General and administrative

     10,736       9,620       43,787       39,982  

(2) Amortization of acquisition-related intangibles included in above line items:

        

Cost of licensing

   $ 6,678     $ 2,789     $ 26,712     $ 2,890  

Cost of products and services

     770       768       3,085       2,350  

Sales and marketing

     354       867       1,765       2,824  

General and administrative

     1,872       1,872       7,488       7,488  

Other income, net

     441       —        1,806       —   
Diluted earnings per share:    Fiscal Quarter Ended     Fiscal Year Ended  
     September 26,
2025
    September 27,
2024
    September 26,
2025
    September 27,
2024
 

GAAP diluted earnings per share

   $ 0.51     $ 0.61     $ 2.62     $ 2.69  

Stock-based compensation

     0.32       0.30       1.32       1.23  

Amortization of acquisition-related intangibles

     0.10       0.06       0.42       0.16  

Restructuring charges/(credits)

     0.06       (0.01     0.15       0.07  

Impact of Tax Reform

     0.09       (0.10     0.09       (0.11

Income tax adjustments

     (0.09     (0.05     (0.36     (0.25
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP diluted earnings per share

   $ 0.99     $ 0.81     $ 4.24     $ 3.79  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted-average shares outstanding - diluted (in thousands)

     96,846       96,593       97,479       97,325  
Impact of discrete tax items:                Fiscal Quarter Ended  
                 September 26, 2025  

Discrete tax items included in GAAP diluted earnings per share

       $         0.19  

Impact of Tax Reform

           0.09  
      

 

 

 

Discrete tax items included in Non-GAAP diluted earnings per share

       $         0.28  
      

 

 

 


The following tables present a reconciliation between GAAP and non-GAAP versions of the estimated financial measures for the first quarter of fiscal 2026 and full year fiscal 2026 included in this release:

 

Gross margin:          Q1 2026           Fiscal 2026  

GAAP gross margin

       88.0       88.0

Stock-based compensation

       0.1       0.1

Amortization of acquisition-related intangibles

       1.9       1.9
    

 

 

     

 

 

 

Non-GAAP gross margin

       90.0       90.0
    

 

 

     

 

 

 
Operating expenses (in millions):          Q1 2026           Fiscal 2026  

GAAP operating expenses (low - high end of range)

     $ 235 - $245       $ 930 - $950  

Stock-based compensation

       (33       (130

Amortization of acquisition-related intangibles

       (2       (10

Restructuring charges

       (5       (10
    

 

 

     

 

 

 

Non-GAAP operating expenses (low - high end of range)

     $ 195 - $205       $ 780 - $800  
    

 

 

     

 

 

 
Operating margin:                      Fiscal 2026  

GAAP operating margin

           21 % +/- 

Stock-based compensation

           9

Amortization of acquisition-related intangibles

           3

Restructuring charges

           1
        

 

 

 

Non-GAAP operating margin

           34 % +/- 
        

 

 

 
Effective tax rate:          Q1 2026           Fiscal 2026  

GAAP effective tax rate

       23.0       23.0

Stock-based compensation (low - high end of range)

       (2%) - 1       (2%) - 0

Amortization of acquisition-related intangibles (low - high end of range)

       (1%) - 0       (1%) - 0
    

 

 

     

 

 

 

Non-GAAP effective tax rate

       21.0       21.0
    

 

 

     

 

 

 
Diluted earnings per share:    Q1 2026     Fiscal 2026  
     Low     High     Low     High  

GAAP diluted earnings per share (low - high end of range)

   $ 0.39     $ 0.54     $ 2.61     $ 2.76  

Stock-based compensation

     0.34       0.34       1.36       1.36  

Amortization of acquisition-related intangibles

     0.11       0.11       0.43       0.43  

Restructuring charges

     0.05       0.05       0.10       0.10  

Income tax adjustments

     (0.10     (0.10     (0.31     (0.31
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP diluted earnings per share (low - high end of range)

   $ 0.79     $ 0.94     $ 4.19     $ 4.34  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted-average shares outstanding - diluted (in thousands)

     96,800       96,800       97,100       97,100  

Investor Contact:

Peter Goldmacher

415-254-7415

peter.goldmacher@dolby.com

Media Contact:

media@dolby.com